Malignant Germ Cell Tumor clinical trials

Explore recruiting malignant germ cell tumor clinical trials.

Recruiting malignant germ cell tumor studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malignant Germ Cell Tumor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EORTC-1407-GUCG: A randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high-dose chemotherapy using mobilizing paclitaxel plus ifosfamide followed by high-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumors (TIGER)

Germany, Netherlands, France, Ireland, Belgium, Spain +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors

Spain, Sweden, Netherlands, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Malignant Germ Cell Tumor trials by city

Malignant Germ Cell Tumor clinical trials

Recruiting malignant germ cell tumor studies right now

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

A Study of DEG6498 in Participants With Solid Tumors

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Chronic CED of TPT for Recurrent Malignant Glioma

HTL0039732 in Participants With Advanced Solid Tumours

Also recruiting in Europe

A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors

Malignant Germ Cell Tumor trials by city

Other conditions